SEC Form 4 · accession 0001104659-17-071439
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francesco Maria Lavino
Officer — Chief Commercial Officer
Period of report
Nov 29, 2017
Accepted (ET)
Dec 1, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 29, 2017 | P | 1,569 | $6.29 | A | 1,569 | D |
Table II — derivative securities
No Table II lines on this filing.